세계의 GABA 보충제 시장 : 세계의 업계 분석, 규모, 점유율, 성장, 동향 - 형태별, 유통 채널별, 국가별 예측(2031년)

GABA Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

US $ 4,995 ￦ 6,947,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,814,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,742,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

GABA 보충제 시장 규모는 2024년 4,531만 달러에서 2031년에는 6,932만 달러로 성장할 것으로 예상되며, 복합 연간 성장률(CAGR)은 6%로 예상됩니다. 이 성장은 휴식을 돕고, 수면의 질을 높이고, 불안을 완화시키는 영양 보충제에 대한 소비자의 의식과 수요 증가를 돋보이게합니다. 캡슐은 수익면에서 시장을 독점하고 향후 몇 년동안 상당한 성장이 예상됩니다.

몇 가지 요인이 GABA 보충제 시장의 성장을 가속하고 있습니다. 이 보충제는 뇌의 휴식을 촉진하고, 스트레스 수준을 낮추고, 수면의 질을 개선하고, 불안과 호르몬의 과민성을 완화하는 등 많은 건강상의 이점을 제공합니다. 스트레스, 불안, 수면장애가 일반적인 오늘날의 눈부신 환경에서는 이러한 이점이 특히 귀중합니다.

Sleep Foundation에 따르면 세계의에서 상당수의 성인이 불면증으로 고통받고 있으며 만성 불면증은 인구의 대부분에 영향을 미칩니다. 일본, 미국, 영국, 한국의 등의 국가에서는 수면에 대한 불만의 수준이 높은 것으로 보고되어 있어, 릴렉스 효과나 수면 개선 효과로 알려진 GABA 보충제에 있어서 큰 기회가 되고 있습니다.

COVID-19의 대유행은 세계의 정신 건강에 큰 영향을 미치고 불안과 우울증의 현저한 증가를 가져옵니다. 이 급증은 휴식을 촉진하고 불안을 완화하는 영양 보조 식품 수요를 밀어 올리고 있습니다. 신경 전달 물질의 기능을 지원하는 것으로 알려진 GABA 보충제는 이러한 정신 건강 문제에 대한 효과적인 솔루션으로 인기를 얻고 있습니다.

이 보고서는 세계의 GABA 보충제 시장을 조사했으며, 시장 개요와 함께 형태별, 유통 채널별, 국가별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나,러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 GABA 보충제 시장 전망(2019년-2031년)

• 세계의 GABA 보충제 시장 전망 : 형태별, 금액별(100만 달러)(2019년-2031년)
• 세계의 GABA 보충 시장 전망 : 유통 채널별, 금액(100만 달러)(2019년-2031년)
• 세계의 GABA 보충 시장 전망 : 지역별, 금액(100만 달러)(2019년-2031년)

제4장 북미의 GABA 보충제 시장 전망(2019년-2031년)

제5장 유럽의 GABA 보충제 시장 전망(2019년-2031년)

제6장 아시아태평양의 GABA 보충제 시장 전망(2019년-2031년)

제7장 라틴아메리카의 GABA 보충제 시장 전망(2019년-2031년)

제8장 중동 및 아프리카의 GABA 보충 시장 전망(2019년-2031년)

제9장 경쟁 구도

• 제조업체별과 유통 채널별 히트 맵
• 기업의 시장 점유율 분석(2024년)
• 경쟁 대시보드
• 기업 프로파일
  • Merz Inc
  • Now Foods
  • Horbaach
  • Pure Encapsulations
  • Thorne
  • VITANICA
  • NutraBio
  • Country Life
  • Integrative Therapeutics
  • Solgar
  • Nusa Pure

제10장 부록

BJH

영문 목차

영문목차

The GABA supplements market is poised for significant expansion, with projections indicating it will grow from $45.31 million in 2024 to $69.32 million by 2031, reflecting a CAGR of 6%. This growth highlights the increasing consumer awareness and demand for dietary supplements that aid relaxation, enhance sleep quality, and reduce anxiety. Capsules are expected to dominate the market in terms of revenue generation, showing substantial growth prospects in the coming years.

Key Factors Driving Market Growth

Several factors are driving the growth of the GABA supplements market. These supplements offer numerous health benefits, such as promoting brain relaxation, lowering stress levels, improving sleep quality, and reducing anxiety and hormonal irritability. In today's fast-paced environment, where stress, anxiety, and sleep disorders are common, these benefits are particularly valuable.

According to the Sleep Foundation, a significant number of adults globally suffer from insomnia, with chronic insomnia affecting a large portion of the population. Countries like Japan, the United States, the United Kingdom, and South Korea report high levels of sleep dissatisfaction, creating a significant opportunity for GABA supplements known for their relaxation and sleep-enhancing properties.

Impact of Covid-19 on Mental Health

The Covid-19 pandemic has significantly impacted mental health worldwide, leading to a marked increase in anxiety and depression. This surge has driven the demand for dietary supplements that promote relaxation and reduce anxiety. GABA supplements, known for supporting neurotransmitter function, are gaining popularity as effective solutions for these mental health concerns.

Addressing PMDD and Hypertension

Premenstrual dysphoric disorder (PMDD) affects many women, causing anxiety, depression, mood swings, and irritability. GABA supplements can help alleviate these symptoms, making them an attractive option for those seeking mental wellness and reduced inflammation.

Hypertension is another growing concern globally, with many adults affected. Studies indicate that GABA supplements can significantly lower blood pressure, offering a potential dietary solution for managing hypertension.

Supporting Underlying Medical Conditions

Individuals with conditions such as Parkinson's disease, hyperactivity disorder, and seizure disorders may have lower GABA levels. In these cases, GABA supplements can provide additional support by inducing calming effects and reducing anxiety.

Regional Market Insights

North America

North America is a leading market for GABA supplements, driven by high levels of chronic stress and anxiety and a significant portion of the population experiencing sleep-related issues.

United States

Anxiety disorders are among the most common mental health issues in the United States, affecting millions of adults annually. Many individuals prefer dietary supplements over traditional treatments to manage their anxiety, presenting a growth opportunity for GABA supplements.

United Kingdom

The United Kingdom has seen a rise in anxiety and depression, especially post-Covid-19. This has led to increased consumption of sleeping pills and anxiety medications, highlighting the need for non-harmful alternatives like GABA supplements.

Japan

Japan faces significant sleep disorder issues, with a large percentage of the population suffering from insomnia. This ongoing problem is driving the demand for GABA dietary supplements as a solution for better sleep and relaxation.

China

China's high prevalence of sleep disorders affects millions of people, influencing the demand for dietary supplements like GABA that promote better sleep and overall wellness.

South Korea

South Korea experiences notable stress and sleep-related issues, contributing to the demand for GABA supplements. The country's focus on skincare and wellness aligns with the benefits of GABA supplements, making them a popular choice for promoting beauty sleep and reducing stress.

Market Form and Competitive Analysis

GABA supplements come in various forms, including capsules, lozenges, powder, and gummies, with capsules projected to witness significant growth due to their convenience and efficacy.

Key players in the GABA supplements market include Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure. These companies offer a wide range of GABA supplements and provide resources such as stress-measuring tests and FAQs on their websites to assist consumers in selecting the best products for their needs.

Market Segmentation

By Form:

• Capsules
• Lozenges
• Powder
• Gummies

By Distribution Channel:

• Online Stores
• Pharmacies
• Supermarkets
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global GABA Supplements Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global GABA Supplements Market Outlook, 2019-2031

• 3.1. Global GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. Capsules
    • 3.1.1.2. Lozenges
    • 3.1.1.3. Powder
    • 3.1.1.4. Gummies
• 3.2. Global GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Online Stores
    • 3.2.1.2. Pharmacies
    • 3.2.1.3. Supermarkets
    • 3.2.1.4. Others
• 3.3. Global GABA Supplements Market Outlook, by Region, Value (US$ Mn), 2019-2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. North America
    • 3.3.1.2. Europe
    • 3.3.1.3. Asia Pacific
    • 3.3.1.4. Latin America
    • 3.3.1.5. Middle East & Africa

4. North America GABA Supplements Market Outlook, 2019-2031

• 4.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Capsules
    • 4.1.1.2. Lozenges
    • 4.1.1.3. Powder
    • 4.1.1.4. Gummies
• 4.2. North America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Online Stores
    • 4.2.1.2. Pharmacies
    • 4.2.1.3. Supermarkets
    • 4.2.1.4. Others
• 4.3. North America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. U.S. GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 4.3.1.2. U.S. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 4.3.1.3. Canada GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 4.3.1.4. Canada GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

5. Europe GABA Supplements Market Outlook, 2019-2031

• 5.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Capsules
    • 5.1.1.2. Lozenges
    • 5.1.1.3. Powder
    • 5.1.1.4. Gummies
• 5.2. Europe GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Online Stores
    • 5.2.1.2. Pharmacies
    • 5.2.1.3. Supermarkets
    • 5.2.1.4. Others
• 5.3. Europe GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Germany GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.2. Germany GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.3.1.3. U.K. GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.4. U.K. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.3.1.5. France GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.6. France GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.3.1.7. Italy GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.8. Italy GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.3.1.9. Turkey GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.10. Turkey GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.3.1.11. Russia GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.12. Russia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 5.3.1.13. Rest of Europe GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 5.3.1.14. Rest of Europe GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

6. Asia Pacific GABA Supplements Market Outlook, 2019-2031

• 6.1. Asia Pacific GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Capsules
    • 6.1.1.2. Lozenges
    • 6.1.1.3. Powder
    • 6.1.1.4. Gummies
• 6.2. Asia Pacific GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Online Stores
    • 6.2.1.2. Pharmacies
    • 6.2.1.3. Supermarkets
    • 6.2.1.4. Others
• 6.3. Asia Pacific GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. China GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 6.3.1.2. China GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 6.3.1.3. Japan GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 6.3.1.4. Japan GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 6.3.1.5. South Korea GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 6.3.1.6. South Korea GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 6.3.1.7. India GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 6.3.1.8. India GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 6.3.1.9. Southeast Asia GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 6.3.1.10. Southeast Asia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 6.3.1.11. Rest of Asia Pacific GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 6.3.1.12. Rest of Asia Pacific GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

7. Latin America GABA Supplements Market Outlook, 2019-2031

• 7.1. Latin America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. Capsules
    • 7.1.1.2. Lozenges
    • 7.1.1.3. Powder
    • 7.1.1.4. Gummies
• 7.2. Latin America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
  • 7.2.1. Key Highlights
    • 7.2.1.1. Online Stores
    • 7.2.1.2. Pharmacies
    • 7.2.1.3. Supermarkets
    • 7.2.1.4. Others
• 7.3. Latin America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Brazil GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 7.3.1.2. Brazil GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 7.3.1.3. Mexico GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 7.3.1.4. Mexico GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 7.3.1.5. Argentina GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 7.3.1.6. Argentina GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 7.3.1.7. Rest of Latin America GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 7.3.1.8. Rest of Latin America GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

8. Middle East & Africa GABA Supplements Market Outlook, 2019-2031

• 8.1. Middle East & Africa GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2019-2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. Capsules
    • 8.1.1.2. Lozenges
    • 8.1.1.3. Powder
    • 8.1.1.4. Gummies
• 8.2. Middle East & Africa GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2019-2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Online Stores
    • 8.2.1.2. Pharmacies
    • 8.2.1.3. Supermarkets
    • 8.2.1.4. Others
• 8.3. Middle East & Africa GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2019-2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. GCC GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 8.3.1.2. GCC GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 8.3.1.3. South Africa GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 8.3.1.4. South Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 8.3.1.5. Egypt GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 8.3.1.6. Egypt GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 8.3.1.7. Nigeria GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 8.3.1.8. Nigeria GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031
    • 8.3.1.9. Rest of Middle East & Africa GABA Supplements Market by Form, Value (US$ Mn), 2019-2031
    • 8.3.1.10. Rest of Middle East & Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2019-2031

9. Competitive Landscape

• 9.1. Manufacturer vs by Distribution Channel Heatmap
• 9.2. Company Market Share Analysis, 2024
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Merz Inc
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Development
  • 9.4.2. Now Foods
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Portfolio
    • 9.4.2.3. Financial Overview
    • 9.4.2.4. Business Strategies and Development
  • 9.4.3. Horbaach
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Product Portfolio
    • 9.4.3.3. Financial Overview
    • 9.4.3.4. Business Strategies and Development
  • 9.4.4. Pure Encapsulations
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Product Portfolio
    • 9.4.4.3. Financial Overview
    • 9.4.4.4. Business Strategies and Development
  • 9.4.5. Thorne
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Portfolio
    • 9.4.5.3. Financial Overview
    • 9.4.5.4. Business Strategies and Development
  • 9.4.6. VITANICA
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Portfolio
    • 9.4.6.3. Financial Overview
    • 9.4.6.4. Business Strategies and Development
  • 9.4.7. NutraBio
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Portfolio
    • 9.4.7.3. Financial Overview
    • 9.4.7.4. Business Strategies and Development
  • 9.4.8. Country Life
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Product Portfolio
    • 9.4.8.3. Financial Overview
    • 9.4.8.4. Business Strategies and Development
  • 9.4.9. Integrative Therapeutics
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Product Portfolio
    • 9.4.9.3. Financial Overview
    • 9.4.9.4. Business Strategies and Development
  • 9.4.10. Solgar
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Product Portfolio
    • 9.4.10.3. Financial Overview
    • 9.4.10.4. Business Strategies and Development
  • 9.4.11. Nusa Pure
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Product Portfolio
    • 9.4.11.3. Financial Overview
    • 9.4.11.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations